Global Large Molecule Bioanalytical Technologies Market Report 2024

The large molecule bioanalytical technologies market size has grown rapidly in recent years. It will grow from $8.9 billion in 2023 to $10.19 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth observed in the historical period can be attributed to several key factors, including increased investment in biotechnology research, the expansion of proteomics research, the growth in high-throughput screening methods, the increased adoption of next-generation sequencing technologies, and the rise in single-cell analysis techniques.

The large molecule bioanalytical technologies market size is expected to see rapid growth in the next few years. It will grow to $17.59 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. Anticipated growth in the forecast period can be attributed to a variety of factors such as the increasing demand for biopharmaceuticals, growing investment in life sciences research, rising demand for point-of-care testing, the increasing prevalence of chronic diseases, and the heightened demand for biologics and biosimilars. Key trends expected in the forecast period include the implementation of real-time analysis, the adoption of quality control labs, the integration of artificial intelligence, advancements in technology, the adoption of cloud-based solutions, and the incorporation of digital technologies.

The increasing focus on personalized medicine is expected to significantly drive the growth of the large molecule bioanalytical technologies market. Personalized medicine involves tailoring medical treatment and healthcare decisions to individual patient characteristics, including genetic makeup, biomarkers, lifestyle, and environmental factors, to optimize efficacy and minimize side effects. Factors such as individual variability in disease susceptibility, the shift towards value-based healthcare, and the emphasis on patient-centered care are propelling the focus on personalized medicine. Large-molecule bioanalytical technologies are essential in drug development for characterizing the pharmacokinetics and pharmacodynamics of large-molecule drugs, such as monoclonal antibodies and gene therapies. For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized medicines for rare disease patients in 2023, up from six in 2022. This trend underscores the growing importance of personalized medicine and drives the demand for advanced bioanalytical technologies.

Leading companies in the large molecule bioanalytical technologies market are developing advanced technologies to enhance the analysis and characterization of large molecules. For example, Fourier transform infrared (FTIR) spectroscopy is a sophisticated technique used to determine the chemical structure of biomolecules. In April 2022, Edinburgh Instruments Ltd. launched the IR5, a benchtop FTIR spectrometer designed for molecular spectroscopy applications. The IR5 offers high sensitivity and spectral resolution, an additional detector for improved sensitivity, and the ability to perform combined absorption and photoluminescence spectroscopy. The instrument is equipped with Miracle software, providing a modern and intuitive user experience.

In March 2021, Charles River Laboratories International Inc. acquired Retrogenix Limited for $48 million. This acquisition aimed to boost Charles River's scientific expertise and capabilities in discovering large molecules and cell therapies. Retrogenix Limited, a UK-based biotechnology company, specializes in a large-molecule discovery platform and offers early-stage contract research organization (CRO) services with a focus on bioanalytical services.

Major companies operating in the large molecule bioanalytical technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Charles River Laboratories International Inc., Intertek Group plc, Shimadzu Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., HORIBA Ltd., SCIEX, Bio-Techne Corporation, Hamilton Company, Promega Corporation, Verder Group, Solvias AG, Analytik Jena AG, Genedata AG, Wyatt Technology Corporation, Nanalysis Corporation, Avomeen Analytical Services, Cergentis B.V., Halo Labs Inc., Hitachi High-Technologies Corporation, Precision NanoSystems Inc.

North America was the largest region in the large molecule bioanalytical technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large molecule bioanalytical technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the large molecule bioanalytical technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Large molecule bioanalytical technologies encompass analytical methods used to examine and evaluate complex biological entities such as proteins and nucleic acids. These technologies are crucial for understanding the structure, functionality, and interactions of these molecules, playing a vital role in drug discovery, clinical diagnostics, and biotechnology research.

The primary categories in the large molecule bioanalytical technologies market include products and services. Products consist of physical items such as instruments, consumables, software, and accessories utilized for the analysis and manipulation of large biological molecules. These technologies encompass a range of methods, including chromatography, mass spectrometry, enzyme-linked immunosorbent assay (ELISA), electrophoresis, polymerase chain reaction (PCR), western blot, flow cytometry, spectrometry, and others. These are applied in various fields such as biologics, oligonucleotide-derived drugs and molecules, viral vectors, cell and gene therapy, nanoparticles and polymers, and disease diagnosis, among others.

The large molecule bioanalytical technologies market research report is one of a series of new reports that provides large molecule bioanalytical technologies market statistics, including large molecule bioanalytical technologies industry global market size, regional shares, competitors with a large molecule bioanalytical technologies market share, detailed large molecule bioanalytical technologies market segments, market trends and opportunities, and any further data you may need to thrive in the large molecule bioanalytical technologies industry. This large molecule bioanalytical technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large molecule bioanalytical technologies market consists of revenues earned by entities by providing services such as analytical testing services, assay development services, and outsourcing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The large molecule bioanalytical technologies market also includes sales of spectrophotometers, pipettes, and microplate readers. values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.